PPT Slide
- It is important to note that underuse is probably more
important than overuse, especially in cardiovascular, respiratory
and psychiatric treatments.
- The proposed system will not yield robust safety data.
- Safety concerns central to therapeutic decision-making will not
be easily addressed by NPDUIS.
How do we obtain the best possible pharmaceutical
outcomes at affordable cost?
Answering this question is the principal justification for
prescription drug use monitoring across provinces.